Yanan Zhu Analyst PerformanceDirector at Wells Fargo & CompanyYanan Zhu is a stock analyst at Wells Fargo & Company in the healthcare sector, covering 25 publicly traded companies. Over the past year, Yanan Zhu has issued 44 stock ratings, including strong buy, buy, and hold recommendations. While full access to Yanan Zhu's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Yanan Zhu's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings66 Last 4 YearsBuy Recommendations75.38% 49 Buy RatingsCompanies Covered25 Unique Companies Ratings Distribution65RatingsDistribution of strong buy, buy, hold, and sell ratings by Yanan Zhu.RatingPercentageCount Strong Buy4.6%3 ratings Buy70.8%46 ratings Hold24.6%16 ratings Sell0.0%0 ratingsOut of 65 total stock ratings issued by Yanan Zhu at Wells Fargo & Company, the majority (70.8%) have been Buy recommendations, followed by 24.6% Hold and 4.6% Strong Buy.Best & Worst CallsBest Call0000.0%BEAMMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%SRPTApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ25 companiesYanan Zhu, an analyst at Wells Fargo & Company, currently covers 25 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare25 companies100.0%Yanan Zhu of Wells Fargo & Company specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY23 companies92.0%PHARMACEUTICALS2 companies8.0% Yanan Zhu's Ratings History at Wells Fargo & Company Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsSYRESpyre Therapeutics8/5/2026Boost Price Target$104.94$115.00Overweight$0.0000.00% ROIQUREuniQure7/30/2026Boost Price Target$40.23$75.00Overweight$0.0000.00% ROIIONSIonis Pharmaceuticals7/30/2026Lower Price Target$53.25$95.00Overweight$0.0000.00% ROIPHVSPharvaris7/15/2026Initiated Coverage$34.42$55.00Overweight$0.0000.00% ROIPHVSPharvaris7/15/2026Upgrade$35.16Strong-Buy$0.0000.00% ROIMGXMetagenomi5/12/2026Lower Price Target$1.34$9.00Overweight$0.0000.00% ROIENGNenGene5/8/2026Reiterated Rating$1.72$2.00Equal Weight$0.0000.00% ROIENGNenGene5/8/2026Downgrade$1.50$2.00Equal Weight$0.0000.00% ROICYTKCytokinetics5/7/2026Boost Price Target$74.64$105.00Overweight$0.0000.00% ROIONCBeOne Medicines5/4/2026Initiated Coverage$293.86$400.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. ONCBeOne Medicines5/4/2026Upgrade$297.49Strong-Buy$0.0000.00% ROISYRESpyre Therapeutics4/14/2026Boost Price Target$63.27$90.00Overweight$0.0000.00% ROICYTKCytokinetics4/10/2026Initiated Coverage$64.59$95.00Overweight$0.0000.00% ROIRNAAvidity Biosciences3/11/2026Initiated Coverage$14.67Overweight$0.0000.00% ROIRNAAvidity Biosciences3/10/2026Upgrade$14.57Strong-Buy$0.0000.00% ROIQUREuniQure3/9/2026Upgrade$14.27$60.00Overweight$0.0000.00% ROIQUREuniQure3/3/2026Reiterated Rating$10.50$15.00Equal Weight$0.0000.00% ROINTLAIntellia Therapeutics3/3/2026Boost Price Target$14.07$15.00Equal Weight$0.0000.00% ROIQUREuniQure3/2/2026Downgrade$9.03$15.00Equal Weight$0.0000.00% ROISRPTSarepta Therapeutics2/27/2026Lower Price Target$16.66$38.00Overweight$0.0000.00% ROIACLXArcellx2/23/2026Downgrade$64.11$115.00Equal Weight$0.0000.00% ROISYRESpyre Therapeutics2/20/2026Boost Price Target$42.03$50.00Overweight$0.0000.00% ROIRAPTRapt Therapeutics1/20/2026Downgrade$57.55$58.00Equal Weight$0.0000.00% ROITSHATaysha Gene Therapies1/5/2026Boost Price Target$5.25$11.00Overweight$0.0000.00% ROIIONSIonis Pharmaceuticals1/5/2026Boost Price Target$79.67$100.00Overweight$0.0000.00% ROIQUREuniQure11/12/2025Lower Price Target$30.26$60.00Overweight$0.0000.00% ROINTLAIntellia Therapeutics11/7/2025Lower Price Target$9.19$12.00Equal Weight$0.0000.00% ROISRPTSarepta Therapeutics11/5/2025Lower Price Target$18.35$45.00Overweight$0.0000.00% ROIRAPTRapt Therapeutics11/3/2025Set Price Target$30.21$72.00Overweight$0.0000.00% ROINTLAIntellia Therapeutics10/28/2025Reiterated Rating$13.95$17.00Equal Weight$0.0000.00% ROINTLAIntellia Therapeutics10/27/2025Downgrade$13.96Hold$0.0000.00% ROIARCTArcturus Therapeutics10/23/2025Lower Price Target$11.08$20.00Overweight$0.0000.00% ROIRAPTRapt Therapeutics10/21/2025Reiterated Rating$33.67$48.00Overweight$0.0000.00% ROICRSPCRISPR Therapeutics10/13/2025Set Price Target$73.07$75.00$0.0000.00% ROIQUREuniQure10/2/2025Boost Price Target$54.99$80.00Overweight$0.0000.00% ROIQUREuniQure9/25/2025Boost Price Target$48.60$65.00Overweight$0.0000.00% ROIEDITEditas Medicine9/3/2025Boost Price Target$2.50$4.00Equal Weight$0.0000.00% ROINAMSNewAmsterdam Pharma8/25/2025Initiated Coverage$25.00$45.00Overweight$0.0000.00% ROIIONSIonis Pharmaceuticals8/22/2025Boost Price Target$43.24$82.00Overweight$0.0000.00% ROIMGXMetagenomi8/14/2025Lower Price Target$1.90$12.00Overweight$0.0000.00% ROIThe end may be near for these iconic stocks (Ad)Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.Watch Marc Chaikin's free presentation and get his full buy-and-sell list todayTSHATaysha Gene Therapies8/13/2025Boost Price Target$2.91$8.00Overweight$0.0000.00% ROIFATEFate Therapeutics8/13/2025Lower Price Target$0.94$2.50Equal Weight$0.0000.00% ROIAUTLAutolus Therapeutics8/13/2025Lower Price Target$2.15$5.00Overweight$0.0000.00% ROIARCTArcturus Therapeutics8/12/2025Lower Price Target$11.39$42.00Overweight$0.0000.00% ROIRAPTRapt Therapeutics8/8/2025Reiterated Rating$10.25$38.00Overweight$0.0000.00% ROINTLAIntellia Therapeutics8/8/2025Reiterated Rating$11.46$45.00Overweight$0.0000.00% ROIIOVAIovance Biotherapeutics8/8/2025Lower Price Target$2.27$14.00Overweight$0.0000.00% ROIRNAAvidity Biosciences8/8/2025Boost Price Target$46.57$75.00Overweight$0.0000.00% ROISRPTSarepta Therapeutics8/7/2025Boost Price Target$17.56$50.00Overweight$00.0000.00% ROISRPTSarepta Therapeutics7/24/2025Lower Price Target$12.33$48.00Overweight$00.0000.00% ROISRPTSarepta Therapeutics7/17/2025Lower Price Target$21.89$65.00Overweight$00.0000.00% ROIMGXMetagenomi5/14/2025Reiterated Rating$1.49$16.00Overweight$0.0000.00% ROIARCTArcturus Therapeutics5/14/2025Lower Price Target$11.11$45.00Overweight$0.0000.00% ROIADAPAdaptimmune Therapeutics5/14/2025Lower Price Target$0.28$1.00Equal Weight$0.0000.00% ROIAFMDAffimed5/13/2025Reiterated Rating$0.13$0.10Equal Weight$0.0000.00% ROIBEAMBeam Therapeutics5/7/2025Lower Price Target$15.78$70.00Overweight$00.0000.00% ROISRPTSarepta Therapeutics4/11/2025Initiated Coverage$50.31$115.00Overweight$00.0000.00% ROIADAPAdaptimmune Therapeutics3/21/2025Lower Price Target$0.29$1.50Equal Weight$0.0000.00% ROIAUTLAutolus Therapeutics3/21/2025Lower Price Target$1.72$6.00Overweight$0.0000.00% ROIMGXMetagenomi3/18/2025Lower Price Target$1.88$20.00Overweight$0.0000.00% ROIVYGRVoyager Therapeutics3/12/2025Set Price Target$3.68$10.00Overweight$0.0000.00% ROIARCTArcturus Therapeutics3/7/2025Lower Price Target$14.73$50.00Overweight$0.0000.00% ROIFATEFate Therapeutics3/6/2025Lower Price Target$0.91$4.00Equal Weight$0.0000.00% ROINTLAIntellia Therapeutics2/28/2025Lower Price Target$9.95$50.00Overweight$00.0000.00% ROINTLAIntellia Therapeutics1/10/2025Lower Price Target$11.50$60.00Overweight$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenJefferies Financial GroupWeiss RatingsUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.The Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank Aktiengesellschaft Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
